0
0

To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.

5/24/2024, 4:05 AM

Current Status of Bill HR 8211

Bill HR 8211 is currently in the status of Bill Introduced since May 1, 2024. Bill HR 8211 was introduced during Congress 118 and was introduced to the House on May 1, 2024.  Bill HR 8211's most recent activity was Referred to the House Committee on the Judiciary. as of May 1, 2024

Bipartisan Support of Bill HR 8211

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
8
Democrat Cosponsors
0
Republican Cosponsors
8
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8211

Primary Policy Focus

Alternate Title(s) of Bill HR 8211

To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.
To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.

Comments